Association between visual hallucinations and α‐synuclein oligomers in patients with dementia with Lewy bodies
Hiroaki Sekiya, Lukas Franke, Daisuke Ono, Michael DeTure, Owen A. Ross, Gregory S. Day, Christian Lachner, Neill R Graff‐Radford, Pamela J. McLean, Tanis J. Ferman, Dennis W. Dickson
TL;DR
This study finds a link between visual hallucinations in dementia with Lewy bodies and increased alpha-synuclein oligomers in a specific brain region.
Contribution
It is the first human brain study to associate alpha-synuclein oligomers with visual hallucinations in dementia with Lewy bodies.
Findings
Patients with visual hallucinations had higher αSYN oligomer burden in the parahippocampal cortex.
Lewy-related pathology levels were similar between patients with and without visual hallucinations.
The findings suggest αSYN oligomers may be a key factor in visual hallucinations in dementia with Lewy bodies.
Abstract
Visual hallucinations (VHs) represent one of the core clinical features of dementia with Lewy bodies (DLB); however, their underlying pathology remains unclear. We employed proximity ligation assay (PLA) and phosphorylated α‐synuclein (αSYN) immunohistochemistry to compare αSYN oligomers and Lewy‐related pathology across brain regions along the ventral visual pathway in patients with and without VHs (five patients each). Greater αSYN oligomer burden in the parahippocampal cortex was observed in patients with VHs compared to those without (p = 0.041), whereas the burden of Lewy‐related pathology was similar between groups. Our findings suggest that αSYN oligomers, rather than conventional Lewy‐related pathology, may be more closely associated with VHs in DLB. This provides novel evidence linking αSYN oligomers to a core clinical feature in DLB and suggests potential therapeutic…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDementia and Cognitive Impairment Research · Parkinson's Disease Mechanisms and Treatments · Hallucinations in medical conditions